Thromboxane b2

Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.

Cross Reference

Introduction

To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Thromboxane b2?

Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Thromboxane b2

MeSH term MeSH ID Detail
Contusions D003288 3 associated lipids
Macular Edema D008269 3 associated lipids
Hydatidiform Mole D006828 3 associated lipids
Aortic Rupture D001019 3 associated lipids
Hemorrhagic Fever with Renal Syndrome D006480 3 associated lipids
Yang Deficiency D016711 3 associated lipids
Bronchopulmonary Sequestration D001998 3 associated lipids
Airway Remodeling D056151 3 associated lipids
Angina Pectoris, Variant D000788 3 associated lipids
Jejunal Diseases D007579 3 associated lipids
Per page 10 20 50 100 | Total 293

PubChem Associated disorders and diseases

What pathways are associated with Thromboxane b2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Thromboxane b2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Thromboxane b2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

What genes are associated with Thromboxane b2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Thromboxane b2

Download all related citations
Per page 10 20 50 100 | Total 6367
Authors Title Published Journal PubMed Link
Emau P et al. Function of prostaglandins, thromboxane A2, and histamine in hypersensitivity reaction to experimental bluetongue disease in calves. 1984 Am. J. Vet. Res. pmid:6093650
Grauer GF et al. Effects of dietary n-3 fatty acid supplementation versus thromboxane synthetase inhibition on gentamicin-induced nephrotoxicosis in healthy male dogs. 1996 Am. J. Vet. Res. pmid:8725828
Baltzer WI et al. Measurement of urinary 11-dehydro-thromboxane B2 excretion in dogs with gastric dilatation-volvulus. 2006 Am. J. Vet. Res. pmid:16426215
Streppa HK et al. Cyclooxygenase selectivity of nonsteroidal anti-inflammatory drugs in canine blood. 2002 Am. J. Vet. Res. pmid:16206787
Ward DS et al. Equine endotoxemia: cardiovascular, eicosanoid, hematologic, blood chemical, and plasma enzyme alterations. 1987 Am. J. Vet. Res. pmid:3307560
Stick JA et al. Thromboxane and prostacyclin production in ponies with colonic volvulus. 1992 Am. J. Vet. Res. pmid:1586029
Semrad SD et al. Effects of concurrent administration of phenylbutazone and flunixin meglumine on pharmacokinetic variables and in vitro generation of thromboxane B2 in mares. 1993 Am. J. Vet. Res. pmid:8291770
Swaim SF et al. Evaluation of the dermal effects of cast padding in coaptation casts on dogs. 1992 Am. J. Vet. Res. pmid:1497201
Cargile JL et al. Effects of tumor necrosis factor blockade on interleukin 6, lactate, thromboxane, and prostacyclin responses in miniature horses given endotoxin. 1995 Am. J. Vet. Res. pmid:8585654
Semrad SD et al. Flunixin meglumine given in small doses: pharmacokinetics and prostaglandin inhibition in healthy horses. 1985 Am. J. Vet. Res. pmid:4083579
Templeton CB et al. Hemodynamics, plasma eicosanoid concentrations, and plasma biochemical changes in calves given multiple injections of Escherichia coli endotoxin. 1988 Am. J. Vet. Res. pmid:3281526
Crutchley DJ et al. Enhanced thromboxane B2 release from challenged guinea pig lung after oxygen exposure. 1980 Am. Rev. Respir. Dis. pmid:6155814
Seeger W and Suttorp N Role of membrane lipids in the pulmonary vascular abnormalities caused by bacterial toxins. 1987 Am. Rev. Respir. Dis. pmid:3113306
Ingenito EP et al. Bronchoalveolar lavage cell and mediator responses to hyperpnea-induced bronchoconstriction in the guinea pig. 1990 Am. Rev. Respir. Dis. pmid:2339838
Hamasaki Y et al. Platelet-activating factor raises airway and vascular pressures and induces edema in lungs perfused with platelet-free solution. 1984 Am. Rev. Respir. Dis. pmid:6547031
Shinozawa Y et al. Ibuprofen prevents synthetic smoke-induced pulmonary edema. 1986 Am. Rev. Respir. Dis. pmid:3538956
Matuschak GM et al. Effects of D-galactosamine-induced acute liver injury on mortality and pulmonary responses to Escherichia coli lipopolysaccharide. Modulation by arachidonic acid metabolites. 1990 Am. Rev. Respir. Dis. pmid:2187385
Kumlin M et al. Urinary excretion of leukotriene E4 and 11-dehydro-thromboxane B2 in response to bronchial provocations with allergen, aspirin, leukotriene D4, and histamine in asthmatics. 1992 Am. Rev. Respir. Dis. pmid:1320824
Seeger W et al. Lung vascular injury after administration of viable hemolysin-forming Escherichia coli in isolated rabbit lungs. 1991 Am. Rev. Respir. Dis. pmid:1826193
Baughman RP et al. Prostaglandins and thromboxanes in the bronchoalveolar lavage fluid: possible immunoregulation in sarcoidosis. 1984 Am. Rev. Respir. Dis. pmid:6388445
Su M et al. Lung mast cells increase in number and degranulate during pulmonary artery occlusion/reperfusion injury in dogs. 1993 Am. Rev. Respir. Dis. pmid:8381632
Johnson A and Malik AB Pulmonary transvascular fluid and protein exchange after thrombin-induced microembolism. Differential effects of cyclooxygenase inhibitors. 1985 Am. Rev. Respir. Dis. pmid:3925828
Wang Y et al. Pulmonary hypertensive response to rabbit blood components in goats: role of thromboxane. 1993 Am. Rev. Respir. Dis. pmid:8466129
Hyman AL et al. Prostaglandins and the lung. 1978 Am. Rev. Respir. Dis. pmid:339796
Ahmed T et al. Endotoxin-induced changes in pulmonary hemodynamics and respiratory mechanics. Role of lipoxygenase and cyclooxygenase products. 1986 Am. Rev. Respir. Dis. pmid:3098146
Loyd JE et al. Corticosteroids prevent acute lung dysfunction caused by thoracic irradiation in unanesthetized sheep. 1988 Am. Rev. Respir. Dis. pmid:3202482
Pretolani M et al. Active immunization induces lung hyperresponsiveness in the guinea pig. Pharmacologic modulation and triggering role of the booster injection. 1988 Am. Rev. Respir. Dis. pmid:3202509
Kubo K and Kobayashi T Effects of OKY-046, a selective thromboxane synthetase inhibitor, on endotoxin-induced lung injury in unanesthetized sheep. 1985 Am. Rev. Respir. Dis. pmid:3898941
Morganroth ML et al. C3a57-77, a C-terminal peptide, causes thromboxane-dependent pulmonary vascular constriction in isolated perfused rat lungs. 1990 Am. Rev. Respir. Dis. pmid:2105683
Laviolette M et al. Human alveolar macrophages: a lesion in arachidonic acid metabolism in cigarette smokers. 1981 Am. Rev. Respir. Dis. pmid:6794395
Miller RF et al. Effect of sulfidopeptide leukotriene receptor antagonists on endotoxin-induced pulmonary dysfunction in awake sheep. 1992 Am. Rev. Respir. Dis. pmid:1416431
Westcott JY et al. Eicosanoid production in isolated perfused lungs stimulated by calcium ionophore A23187. 1988 Am. Rev. Respir. Dis. pmid:3144209
Jones DK et al. Release of von Willebrand factor antigen (vWF:Ag) and eicosanoids during acute injury to the isolated rat lung. 1992 Am. Rev. Respir. Dis. pmid:1596010
Barst RJ et al. Relation of arachidonate metabolites to abnormal control of the pulmonary circulation in a child. 1985 Am. Rev. Respir. Dis. pmid:3917630
Gray PR et al. The role of cyclooxygenase products in the acute airway obstruction and airway hyperreactivity of ponies with heaves. 1989 Am. Rev. Respir. Dis. pmid:2502051
Farrukh IS et al. The role of cyclooxygenase and lipoxygenase mediators in oxidant-induced lung injury. 1988 Am. Rev. Respir. Dis. pmid:3144200
Snapper JR et al. Effects of repetitive bolus injections of zymosan-activated plasma on lung mechanics and airway responsiveness in awake sheep. 1991 Am. Rev. Respir. Dis. pmid:2001069
Gibson RL et al. Group B streptococcus induces tumor necrosis factor in neonatal piglets. Effect of the tumor necrosis factor inhibitor pentoxifylline on hemodynamics and gas exchange. 1991 Am. Rev. Respir. Dis. pmid:2001073
Li JX et al. Capsular type-specific polysaccharide partially inhibits group B Streptococcus-induced pulmonary hypertension. 1993 Am. Rev. Respir. Dis. pmid:8317791
Ogletree ML et al. Influence of steroidal and nonsteroidal anti-inflammatory agents on the accumulation of arachidonic acid metabolites in plasma and lung lymph after endotoxemia in awake sheep. Measurements of prostacyclin and thromboxane metabolites and 12-HETE. 1986 Am. Rev. Respir. Dis. pmid:3079978
Peters-Golden M and Thebert P Inhibition by methylprednisolone of zymosan-induced leukotriene synthesis in alveolar macrophages. 1987 Am. Rev. Respir. Dis. pmid:3034108
Kitazawa K et al. Effects of methylprednisolone on acute lung paraquat toxicity in sheep. 1988 Am. Rev. Respir. Dis. pmid:3122611
Balter MS et al. Arachidonic acid metabolism in cultured alveolar macrophages from normal, atopic, and asthmatic subjects. 1988 Am. Rev. Respir. Dis. pmid:3144211
Kouzan S et al. Stimulation of arachidonic acid metabolism by adherence of alveolar macrophages to a plastic substrate. Modulation by fetal bovine serum. 1988 Am. Rev. Respir. Dis. pmid:2827547
Graham LM et al. Decreased pulmonary vasoreactivity in an animal model of chronic Pseudomonas pneumonia. 1990 Am. Rev. Respir. Dis. pmid:2368972
Chanez P et al. Increased numbers of hypodense alveolar macrophages in patients with bronchial asthma. 1991 Am. Rev. Respir. Dis. pmid:1656824
Ljungman AG et al. Inhibition of cyclooxygenase metabolite production attenuates ischemia-reperfusion lung injury. 1991 Am. Rev. Respir. Dis. pmid:1900402
Wang D et al. Terbutaline acts at multiple sites to inhibit bronchoconstriction induced by dry air in canine peripheral airways. 1992 Am. Rev. Respir. Dis. pmid:1595994
Kleeberger SR et al. The role of mediators in the response of the canine peripheral lung to 1 ppm ozone. 1988 Am. Rev. Respir. Dis. pmid:2829670
Sterk PJ et al. Limited maximal airway narrowing in nonasthmatic subjects. Role of neural control and prostaglandin release. 1985 Am. Rev. Respir. Dis. pmid:2864892